nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—PRKD3—IgA glomerulonephritis	0.196	0.267	CbGaD
Crizotinib—DCLK1—IgA glomerulonephritis	0.149	0.202	CbGaD
Crizotinib—YES1—IgA glomerulonephritis	0.103	0.14	CbGaD
Crizotinib—ACVR1—IgA glomerulonephritis	0.0957	0.13	CbGaD
Crizotinib—MERTK—IgA glomerulonephritis	0.0814	0.111	CbGaD
Crizotinib—AURKA—IgA glomerulonephritis	0.0617	0.0839	CbGaD
Crizotinib—CSF1R—IgA glomerulonephritis	0.049	0.0666	CbGaD
Crizotinib—INSRR—kidney—IgA glomerulonephritis	0.00332	0.0442	CbGeAlD
Crizotinib—PRKD1—nephron tubule—IgA glomerulonephritis	0.00153	0.0203	CbGeAlD
Crizotinib—NEK9—kidney—IgA glomerulonephritis	0.00147	0.0196	CbGeAlD
Crizotinib—PRKD1—kidney—IgA glomerulonephritis	0.00134	0.0178	CbGeAlD
Crizotinib—PRKD3—kidney—IgA glomerulonephritis	0.00129	0.0171	CbGeAlD
Crizotinib—NEK9—lymphoid tissue—IgA glomerulonephritis	0.00126	0.0168	CbGeAlD
Crizotinib—DSTYK—cortex of kidney—IgA glomerulonephritis	0.00123	0.0163	CbGeAlD
Crizotinib—MET—kidney—IgA glomerulonephritis	0.00112	0.0148	CbGeAlD
Crizotinib—BLK—lymphoid tissue—IgA glomerulonephritis	0.00107	0.0142	CbGeAlD
Crizotinib—ACVR1B—kidney—IgA glomerulonephritis	0.00103	0.0137	CbGeAlD
Crizotinib—MAPK7—lymphoid tissue—IgA glomerulonephritis	0.00102	0.0136	CbGeAlD
Crizotinib—TXK—lymphoid tissue—IgA glomerulonephritis	0.00102	0.0136	CbGeAlD
Crizotinib—MET—lymphoid tissue—IgA glomerulonephritis	0.000958	0.0127	CbGeAlD
Crizotinib—TESK1—nephron tubule—IgA glomerulonephritis	0.000938	0.0125	CbGeAlD
Crizotinib—CDK7—lymphoid tissue—IgA glomerulonephritis	0.000926	0.0123	CbGeAlD
Crizotinib—NUAK2—nephron tubule—IgA glomerulonephritis	0.000889	0.0118	CbGeAlD
Crizotinib—FER—cortex of kidney—IgA glomerulonephritis	0.000889	0.0118	CbGeAlD
Crizotinib—ACVR1—nephron tubule—IgA glomerulonephritis	0.000883	0.0117	CbGeAlD
Crizotinib—IGF1R—kidney—IgA glomerulonephritis	0.000877	0.0116	CbGeAlD
Crizotinib—JAK3—lymphoid tissue—IgA glomerulonephritis	0.000845	0.0112	CbGeAlD
Crizotinib—PLK4—lymphoid tissue—IgA glomerulonephritis	0.000834	0.0111	CbGeAlD
Crizotinib—AURKA—kidney—IgA glomerulonephritis	0.000831	0.011	CbGeAlD
Crizotinib—STK3—cortex of kidney—IgA glomerulonephritis	0.00083	0.011	CbGeAlD
Crizotinib—STK4—lymphoid tissue—IgA glomerulonephritis	0.000829	0.011	CbGeAlD
Crizotinib—TESK1—cortex of kidney—IgA glomerulonephritis	0.000803	0.0107	CbGeAlD
Crizotinib—RIPK2—nephron tubule—IgA glomerulonephritis	0.000797	0.0106	CbGeAlD
Crizotinib—FER—lymphoid tissue—IgA glomerulonephritis	0.000784	0.0104	CbGeAlD
Crizotinib—TYRO3—lymphoid tissue—IgA glomerulonephritis	0.000784	0.0104	CbGeAlD
Crizotinib—ALK—lymphoid tissue—IgA glomerulonephritis	0.000784	0.0104	CbGeAlD
Crizotinib—LYN—lymphoid tissue—IgA glomerulonephritis	0.00078	0.0104	CbGeAlD
Crizotinib—ACVR1—kidney—IgA glomerulonephritis	0.000776	0.0103	CbGeAlD
Crizotinib—MAP4K1—lymphoid tissue—IgA glomerulonephritis	0.000768	0.0102	CbGeAlD
Crizotinib—LIMK2—cortex of kidney—IgA glomerulonephritis	0.000764	0.0101	CbGeAlD
Crizotinib—NUAK2—cortex of kidney—IgA glomerulonephritis	0.000761	0.0101	CbGeAlD
Crizotinib—MAP3K2—nephron tubule—IgA glomerulonephritis	0.000756	0.01	CbGeAlD
Crizotinib—ACVR1—cortex of kidney—IgA glomerulonephritis	0.000755	0.01	CbGeAlD
Crizotinib—IGF1R—lymphoid tissue—IgA glomerulonephritis	0.000753	0.01	CbGeAlD
Crizotinib—MAP4K2—lymphoid tissue—IgA glomerulonephritis	0.000742	0.00987	CbGeAlD
Crizotinib—TBK1—nephron tubule—IgA glomerulonephritis	0.00074	0.00984	CbGeAlD
Crizotinib—PTK2—nephron tubule—IgA glomerulonephritis	0.00074	0.00984	CbGeAlD
Crizotinib—TYK2—nephron tubule—IgA glomerulonephritis	0.000735	0.00977	CbGeAlD
Crizotinib—IRAK1—nephron tubule—IgA glomerulonephritis	0.000726	0.00965	CbGeAlD
Crizotinib—AURKA—lymphoid tissue—IgA glomerulonephritis	0.000714	0.00949	CbGeAlD
Crizotinib—PTK2B—kidney—IgA glomerulonephritis	0.000707	0.00939	CbGeAlD
Crizotinib—MERTK—lymphoid tissue—IgA glomerulonephritis	0.000689	0.00915	CbGeAlD
Crizotinib—SLK—nephron tubule—IgA glomerulonephritis	0.000679	0.00902	CbGeAlD
Crizotinib—EPHB4—nephron tubule—IgA glomerulonephritis	0.000674	0.00895	CbGeAlD
Crizotinib—LIMK2—lymphoid tissue—IgA glomerulonephritis	0.000673	0.00895	CbGeAlD
Crizotinib—FLT3—lymphoid tissue—IgA glomerulonephritis	0.000666	0.00886	CbGeAlD
Crizotinib—CYP3A4—urine—IgA glomerulonephritis	0.000663	0.00882	CbGeAlD
Crizotinib—EPHA2—nephron tubule—IgA glomerulonephritis	0.000661	0.00878	CbGeAlD
Crizotinib—PTK2—kidney—IgA glomerulonephritis	0.000651	0.00865	CbGeAlD
Crizotinib—TBK1—kidney—IgA glomerulonephritis	0.000651	0.00865	CbGeAlD
Crizotinib—TYK2—kidney—IgA glomerulonephritis	0.000646	0.00859	CbGeAlD
Crizotinib—MAP3K3—nephron tubule—IgA glomerulonephritis	0.000645	0.00857	CbGeAlD
Crizotinib—TBK1—cortex of kidney—IgA glomerulonephritis	0.000634	0.00842	CbGeAlD
Crizotinib—PTK2—cortex of kidney—IgA glomerulonephritis	0.000634	0.00842	CbGeAlD
Crizotinib—TYK2—cortex of kidney—IgA glomerulonephritis	0.000629	0.00836	CbGeAlD
Crizotinib—RPS6KB1—kidney—IgA glomerulonephritis	0.000626	0.00832	CbGeAlD
Crizotinib—IRAK1—cortex of kidney—IgA glomerulonephritis	0.000621	0.00826	CbGeAlD
Crizotinib—RPS6KB1—cortex of kidney—IgA glomerulonephritis	0.00061	0.0081	CbGeAlD
Crizotinib—PTK2B—lymphoid tissue—IgA glomerulonephritis	0.000607	0.00807	CbGeAlD
Crizotinib—AXL—cortex of kidney—IgA glomerulonephritis	0.000603	0.00802	CbGeAlD
Crizotinib—YES1—nephron tubule—IgA glomerulonephritis	0.000595	0.00791	CbGeAlD
Crizotinib—EPHB4—kidney—IgA glomerulonephritis	0.000592	0.00787	CbGeAlD
Crizotinib—JAK2—kidney—IgA glomerulonephritis	0.000588	0.00781	CbGeAlD
Crizotinib—TAOK3—nephron tubule—IgA glomerulonephritis	0.000588	0.00781	CbGeAlD
Crizotinib—SLK—cortex of kidney—IgA glomerulonephritis	0.000581	0.00772	CbGeAlD
Crizotinib—EPHB4—cortex of kidney—IgA glomerulonephritis	0.000577	0.00766	CbGeAlD
Crizotinib—JAK2—cortex of kidney—IgA glomerulonephritis	0.000573	0.00761	CbGeAlD
Crizotinib—MAP3K2—lymphoid tissue—IgA glomerulonephritis	0.000571	0.00758	CbGeAlD
Crizotinib—TEK—kidney—IgA glomerulonephritis	0.000567	0.00753	CbGeAlD
Crizotinib—PTK2—lymphoid tissue—IgA glomerulonephritis	0.000559	0.00743	CbGeAlD
Crizotinib—TBK1—lymphoid tissue—IgA glomerulonephritis	0.000559	0.00743	CbGeAlD
Crizotinib—TYK2—lymphoid tissue—IgA glomerulonephritis	0.000555	0.00738	CbGeAlD
Crizotinib—TEK—cortex of kidney—IgA glomerulonephritis	0.000552	0.00733	CbGeAlD
Crizotinib—MAP4K5—cortex of kidney—IgA glomerulonephritis	0.000552	0.00733	CbGeAlD
Crizotinib—MAP3K3—cortex of kidney—IgA glomerulonephritis	0.000552	0.00733	CbGeAlD
Crizotinib—RPS6KB1—lymphoid tissue—IgA glomerulonephritis	0.000538	0.00714	CbGeAlD
Crizotinib—FGR—lymphoid tissue—IgA glomerulonephritis	0.000534	0.0071	CbGeAlD
Crizotinib—AXL—lymphoid tissue—IgA glomerulonephritis	0.000532	0.00707	CbGeAlD
Crizotinib—EPHB6—cortex of kidney—IgA glomerulonephritis	0.000527	0.00701	CbGeAlD
Crizotinib—YES1—kidney—IgA glomerulonephritis	0.000523	0.00696	CbGeAlD
Crizotinib—STK10—kidney—IgA glomerulonephritis	0.000519	0.00689	CbGeAlD
Crizotinib—TAOK3—kidney—IgA glomerulonephritis	0.000517	0.00687	CbGeAlD
Crizotinib—YES1—cortex of kidney—IgA glomerulonephritis	0.00051	0.00677	CbGeAlD
Crizotinib—JAK2—lymphoid tissue—IgA glomerulonephritis	0.000505	0.00671	CbGeAlD
Crizotinib—SRC—kidney—IgA glomerulonephritis	0.000503	0.00669	CbGeAlD
Crizotinib—TAOK3—cortex of kidney—IgA glomerulonephritis	0.000503	0.00669	CbGeAlD
Crizotinib—EPHA2—lymphoid tissue—IgA glomerulonephritis	0.000499	0.00663	CbGeAlD
Crizotinib—MAP4K5—lymphoid tissue—IgA glomerulonephritis	0.000487	0.00647	CbGeAlD
Crizotinib—TEK—lymphoid tissue—IgA glomerulonephritis	0.000487	0.00647	CbGeAlD
Crizotinib—YES1—lymphoid tissue—IgA glomerulonephritis	0.000449	0.00597	CbGeAlD
Crizotinib—STK10—lymphoid tissue—IgA glomerulonephritis	0.000445	0.00592	CbGeAlD
Crizotinib—TAOK3—lymphoid tissue—IgA glomerulonephritis	0.000444	0.0059	CbGeAlD
Crizotinib—SRC—lymphoid tissue—IgA glomerulonephritis	0.000432	0.00575	CbGeAlD
Crizotinib—ABL1—nephron tubule—IgA glomerulonephritis	0.000407	0.0054	CbGeAlD
Crizotinib—CSF1R—lymphoid tissue—IgA glomerulonephritis	0.000388	0.00516	CbGeAlD
Crizotinib—ABL1—kidney—IgA glomerulonephritis	0.000357	0.00475	CbGeAlD
Crizotinib—ABL1—cortex of kidney—IgA glomerulonephritis	0.000348	0.00462	CbGeAlD
Crizotinib—ABL1—lymphoid tissue—IgA glomerulonephritis	0.000307	0.00408	CbGeAlD
Crizotinib—CYP3A5—nephron tubule—IgA glomerulonephritis	0.000238	0.00316	CbGeAlD
Crizotinib—CYP3A5—kidney—IgA glomerulonephritis	0.000209	0.00278	CbGeAlD
Crizotinib—CYP3A5—cortex of kidney—IgA glomerulonephritis	0.000204	0.00271	CbGeAlD
Crizotinib—CYP3A4—kidney—IgA glomerulonephritis	0.000157	0.00209	CbGeAlD
Crizotinib—ABCB1—nephron tubule—IgA glomerulonephritis	0.000126	0.00168	CbGeAlD
Crizotinib—ABCB1—kidney—IgA glomerulonephritis	0.000111	0.00148	CbGeAlD
Crizotinib—ABCB1—cortex of kidney—IgA glomerulonephritis	0.000108	0.00144	CbGeAlD
Crizotinib—ABCB1—lymphoid tissue—IgA glomerulonephritis	9.54e-05	0.00127	CbGeAlD
Crizotinib—LYN—Immune System—CD4—IgA glomerulonephritis	7.45e-07	3.93e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—SERPINE1—IgA glomerulonephritis	7.44e-07	3.93e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD4—IgA glomerulonephritis	7.41e-07	3.91e-06	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—TGFB1—IgA glomerulonephritis	7.4e-07	3.9e-06	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—MAPK1—IgA glomerulonephritis	7.39e-07	3.9e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—CD80—IgA glomerulonephritis	7.38e-07	3.89e-06	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—MAPK1—IgA glomerulonephritis	7.38e-07	3.89e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—PTEN—IgA glomerulonephritis	7.35e-07	3.88e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—SERPINE1—IgA glomerulonephritis	7.34e-07	3.87e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MAP3K7—IgA glomerulonephritis	7.32e-07	3.86e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—NRAS—IgA glomerulonephritis	7.32e-07	3.86e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—SERPINE1—IgA glomerulonephritis	7.31e-07	3.86e-06	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—PIK3CA—IgA glomerulonephritis	7.31e-07	3.85e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—H2AFZ—IgA glomerulonephritis	7.28e-07	3.84e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MMP9—IgA glomerulonephritis	7.27e-07	3.83e-06	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—MAPK1—IgA glomerulonephritis	7.25e-07	3.83e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CCL2—IgA glomerulonephritis	7.24e-07	3.82e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ADAM10—IgA glomerulonephritis	7.23e-07	3.82e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—NRAS—IgA glomerulonephritis	7.23e-07	3.81e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—PTEN—IgA glomerulonephritis	7.22e-07	3.81e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IFNG—IgA glomerulonephritis	7.22e-07	3.81e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ABCA1—IgA glomerulonephritis	7.21e-07	3.81e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—RHOA—IgA glomerulonephritis	7.18e-07	3.79e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCR5—IgA glomerulonephritis	7.17e-07	3.78e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—NRAS—IgA glomerulonephritis	7.17e-07	3.78e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CCNC—IgA glomerulonephritis	7.16e-07	3.78e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GNS—IgA glomerulonephritis	7.16e-07	3.78e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MMP9—IgA glomerulonephritis	7.16e-07	3.78e-06	CbGpPWpGaD
Crizotinib—PTK2—Immune System—MAPK1—IgA glomerulonephritis	7.13e-07	3.76e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—PTEN—IgA glomerulonephritis	7.12e-07	3.75e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—AGT—IgA glomerulonephritis	7.12e-07	3.75e-06	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—PIK3CA—IgA glomerulonephritis	7.11e-07	3.75e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—NRAS—IgA glomerulonephritis	7.1e-07	3.75e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—MAPK1—IgA glomerulonephritis	7.08e-07	3.74e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—RHOA—IgA glomerulonephritis	7.08e-07	3.73e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD80—IgA glomerulonephritis	7.08e-07	3.73e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—RHOA—IgA glomerulonephritis	7.06e-07	3.72e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—NAMPT—IgA glomerulonephritis	7.04e-07	3.72e-06	CbGpPWpGaD
Crizotinib—YES1—Immune System—MAPK1—IgA glomerulonephritis	7.03e-07	3.71e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—C3—IgA glomerulonephritis	7.01e-07	3.7e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD4—IgA glomerulonephritis	6.97e-07	3.68e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—SERPINE1—IgA glomerulonephritis	6.96e-07	3.67e-06	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—NRAS—IgA glomerulonephritis	6.88e-07	3.63e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—IQGAP1—IgA glomerulonephritis	6.87e-07	3.62e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MMP9—IgA glomerulonephritis	6.85e-07	3.61e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—PTEN—IgA glomerulonephritis	6.81e-07	3.59e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—VAV3—IgA glomerulonephritis	6.79e-07	3.58e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—SERPINE1—IgA glomerulonephritis	6.76e-07	3.56e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HPSE—IgA glomerulonephritis	6.74e-07	3.55e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TGFB1—IgA glomerulonephritis	6.72e-07	3.54e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—RHOA—IgA glomerulonephritis	6.72e-07	3.54e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—MAPK1—IgA glomerulonephritis	6.67e-07	3.52e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—AGT—IgA glomerulonephritis	6.66e-07	3.51e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—MMP9—IgA glomerulonephritis	6.64e-07	3.5e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—PTEN—IgA glomerulonephritis	6.61e-07	3.48e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—MAPK1—IgA glomerulonephritis	6.59e-07	3.47e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—NRAS—IgA glomerulonephritis	6.56e-07	3.46e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—CD80—IgA glomerulonephritis	6.53e-07	3.45e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—YWHAZ—IgA glomerulonephritis	6.53e-07	3.45e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—MAPK1—IgA glomerulonephritis	6.53e-07	3.44e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—RHOA—IgA glomerulonephritis	6.52e-07	3.44e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—MAPK1—IgA glomerulonephritis	6.47e-07	3.41e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—PTEN—IgA glomerulonephritis	6.45e-07	3.4e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—NRAS—IgA glomerulonephritis	6.44e-07	3.4e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—CD4—IgA glomerulonephritis	6.43e-07	3.39e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—PTEN—IgA glomerulonephritis	6.42e-07	3.38e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—SERPINE1—IgA glomerulonephritis	6.41e-07	3.38e-06	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—PIK3CA—IgA glomerulonephritis	6.4e-07	3.38e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HMMR—IgA glomerulonephritis	6.39e-07	3.37e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—UCP2—IgA glomerulonephritis	6.39e-07	3.37e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—NRAS—IgA glomerulonephritis	6.35e-07	3.35e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IFNG—IgA glomerulonephritis	6.32e-07	3.33e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PSME3—IgA glomerulonephritis	6.31e-07	3.33e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CD80—IgA glomerulonephritis	6.31e-07	3.33e-06	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—PIK3CA—IgA glomerulonephritis	6.29e-07	3.32e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCR5—IgA glomerulonephritis	6.28e-07	3.31e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—HMOX1—IgA glomerulonephritis	6.19e-07	3.26e-06	CbGpPWpGaD
Crizotinib—PTK2—Immune System—PIK3CA—IgA glomerulonephritis	6.18e-07	3.26e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ACSL1—IgA glomerulonephritis	6.18e-07	3.26e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—RHOA—IgA glomerulonephritis	6.18e-07	3.26e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—PIK3CA—IgA glomerulonephritis	6.15e-07	3.24e-06	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—PIK3CA—IgA glomerulonephritis	6.15e-07	3.24e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—C3—IgA glomerulonephritis	6.14e-07	3.24e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD4—IgA glomerulonephritis	6.1e-07	3.22e-06	CbGpPWpGaD
Crizotinib—YES1—Immune System—PIK3CA—IgA glomerulonephritis	6.1e-07	3.22e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—TGFB1—IgA glomerulonephritis	6.09e-07	3.21e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—NRAS—IgA glomerulonephritis	6.08e-07	3.21e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—PTEN—IgA glomerulonephritis	6.03e-07	3.18e-06	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ALB—IgA glomerulonephritis	5.99e-07	3.16e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TGFB1—IgA glomerulonephritis	5.99e-07	3.16e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—MAPK1—IgA glomerulonephritis	5.98e-07	3.15e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CD80—IgA glomerulonephritis	5.9e-07	3.11e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TGFB1—IgA glomerulonephritis	5.9e-07	3.11e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—NRAS—IgA glomerulonephritis	5.89e-07	3.11e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—NRAS—IgA glomerulonephritis	5.89e-07	3.11e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MAPK1—IgA glomerulonephritis	5.87e-07	3.1e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CCL2—IgA glomerulonephritis	5.86e-07	3.09e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SEC23A—IgA glomerulonephritis	5.84e-07	3.08e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TBL1XR1—IgA glomerulonephritis	5.84e-07	3.08e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—TYMS—IgA glomerulonephritis	5.84e-07	3.08e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—AGT—IgA glomerulonephritis	5.83e-07	3.08e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MAPK1—IgA glomerulonephritis	5.79e-07	3.05e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—PIK3CA—IgA glomerulonephritis	5.78e-07	3.05e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—YWHAZ—IgA glomerulonephritis	5.78e-07	3.05e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—NRAS—IgA glomerulonephritis	5.75e-07	3.03e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—NRAS—IgA glomerulonephritis	5.72e-07	3.02e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—PIK3CA—IgA glomerulonephritis	5.72e-07	3.02e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MMP9—IgA glomerulonephritis	5.7e-07	3.01e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALOX5AP—IgA glomerulonephritis	5.69e-07	3e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CD44—IgA glomerulonephritis	5.68e-07	3e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—SERPINE1—IgA glomerulonephritis	5.67e-07	2.99e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—PTEN—IgA glomerulonephritis	5.67e-07	2.99e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—PIK3CA—IgA glomerulonephritis	5.67e-07	2.99e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TGFB1—IgA glomerulonephritis	5.65e-07	2.98e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—CD4—IgA glomerulonephritis	5.64e-07	2.97e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MMP9—IgA glomerulonephritis	5.62e-07	2.97e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—PIK3CA—IgA glomerulonephritis	5.62e-07	2.96e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IFNG—IgA glomerulonephritis	5.59e-07	2.95e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—PTEN—IgA glomerulonephritis	5.59e-07	2.95e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—PTEN—IgA glomerulonephritis	5.57e-07	2.94e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCR5—IgA glomerulonephritis	5.56e-07	2.93e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MAPK1—IgA glomerulonephritis	5.54e-07	2.92e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCL2—IgA glomerulonephritis	5.49e-07	2.89e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TGFB1—IgA glomerulonephritis	5.48e-07	2.89e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SERPINE1—IgA glomerulonephritis	5.47e-07	2.89e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—RHOA—IgA glomerulonephritis	5.47e-07	2.89e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ABCA1—IgA glomerulonephritis	5.44e-07	2.87e-06	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—PIK3CA—IgA glomerulonephritis	5.44e-07	2.87e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—C3—IgA glomerulonephritis	5.44e-07	2.87e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD4—IgA glomerulonephritis	5.4e-07	2.85e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—NRAS—IgA glomerulonephritis	5.38e-07	2.84e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CD36—IgA glomerulonephritis	5.38e-07	2.84e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—MAPK1—IgA glomerulonephritis	5.37e-07	2.83e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—MAPK1—IgA glomerulonephritis	5.37e-07	2.83e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MMP9—IgA glomerulonephritis	5.33e-07	2.81e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—PTEN—IgA glomerulonephritis	5.3e-07	2.8e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—PTEN—IgA glomerulonephritis	5.28e-07	2.79e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—RHOA—IgA glomerulonephritis	5.28e-07	2.78e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—MAPK1—IgA glomerulonephritis	5.24e-07	2.76e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—MAPK1—IgA glomerulonephritis	5.22e-07	2.75e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—PIK3CA—IgA glomerulonephritis	5.18e-07	2.73e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MMP9—IgA glomerulonephritis	5.18e-07	2.73e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CD80—IgA glomerulonephritis	5.17e-07	2.73e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—AGT—IgA glomerulonephritis	5.17e-07	2.72e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—PTEN—IgA glomerulonephritis	5.15e-07	2.71e-06	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—PIK3CA—IgA glomerulonephritis	5.13e-07	2.71e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SERPINE1—IgA glomerulonephritis	5.12e-07	2.7e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—PIK3CA—IgA glomerulonephritis	5.1e-07	2.69e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NRAS—IgA glomerulonephritis	5.06e-07	2.67e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—PIK3CA—IgA glomerulonephritis	5.02e-07	2.65e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—CD4—IgA glomerulonephritis	4.99e-07	2.63e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NRAS—IgA glomerulonephritis	4.99e-07	2.63e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—NRAS—IgA glomerulonephritis	4.97e-07	2.62e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—RHOA—IgA glomerulonephritis	4.94e-07	2.61e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—MAPK1—IgA glomerulonephritis	4.9e-07	2.59e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—PTEN—IgA glomerulonephritis	4.88e-07	2.57e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—AGT—IgA glomerulonephritis	4.84e-07	2.55e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—PIK3CA—IgA glomerulonephritis	4.81e-07	2.53e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCL2—IgA glomerulonephritis	4.81e-07	2.53e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NRAS—IgA glomerulonephritis	4.73e-07	2.49e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—NRAS—IgA glomerulonephritis	4.71e-07	2.49e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFB1—IgA glomerulonephritis	4.7e-07	2.48e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—RRM2—IgA glomerulonephritis	4.69e-07	2.47e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GNG12—IgA glomerulonephritis	4.69e-07	2.47e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—PTEN—IgA glomerulonephritis	4.68e-07	2.47e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—HMOX1—IgA glomerulonephritis	4.67e-07	2.46e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—PIK3CA—IgA glomerulonephritis	4.66e-07	2.46e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—PIK3CA—IgA glomerulonephritis	4.66e-07	2.46e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFB1—IgA glomerulonephritis	4.63e-07	2.44e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFB1—IgA glomerulonephritis	4.62e-07	2.44e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MAPK1—IgA glomerulonephritis	4.61e-07	2.43e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NRAS—IgA glomerulonephritis	4.59e-07	2.42e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CD80—IgA glomerulonephritis	4.58e-07	2.41e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—PIK3CA—IgA glomerulonephritis	4.55e-07	2.4e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MAPK1—IgA glomerulonephritis	4.54e-07	2.4e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—MAPK1—IgA glomerulonephritis	4.53e-07	2.39e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—PIK3CA—IgA glomerulonephritis	4.53e-07	2.39e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SERPINE1—IgA glomerulonephritis	4.49e-07	2.37e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—TYMS—IgA glomerulonephritis	4.4e-07	2.32e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFB1—IgA glomerulonephritis	4.4e-07	2.32e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—NRAS—IgA glomerulonephritis	4.35e-07	2.3e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NAMPT—IgA glomerulonephritis	4.34e-07	2.29e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—RHOA—IgA glomerulonephritis	4.33e-07	2.28e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—PTEN—IgA glomerulonephritis	4.32e-07	2.28e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MAPK1—IgA glomerulonephritis	4.31e-07	2.27e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—MAPK1—IgA glomerulonephritis	4.3e-07	2.27e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFB1—IgA glomerulonephritis	4.27e-07	2.25e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—PIK3CA—IgA glomerulonephritis	4.26e-07	2.24e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCL2—IgA glomerulonephritis	4.25e-07	2.24e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP9—IgA glomerulonephritis	4.19e-07	2.21e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MAPK1—IgA glomerulonephritis	4.18e-07	2.21e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—NRAS—IgA glomerulonephritis	4.17e-07	2.2e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PTEN—IgA glomerulonephritis	4.17e-07	2.2e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CD36—IgA glomerulonephritis	4.06e-07	2.14e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFB1—IgA glomerulonephritis	4.04e-07	2.13e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—PIK3CA—IgA glomerulonephritis	4e-07	2.11e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SERPINE1—IgA glomerulonephritis	3.97e-07	2.09e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—MAPK1—IgA glomerulonephritis	3.97e-07	2.09e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—PIK3CA—IgA glomerulonephritis	3.94e-07	2.08e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—PIK3CA—IgA glomerulonephritis	3.93e-07	2.07e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP9—IgA glomerulonephritis	3.92e-07	2.07e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PTEN—IgA glomerulonephritis	3.9e-07	2.06e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PSME3—IgA glomerulonephritis	3.89e-07	2.05e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—NRAS—IgA glomerulonephritis	3.85e-07	2.03e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—RHOA—IgA glomerulonephritis	3.83e-07	2.02e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—MAPK1—IgA glomerulonephritis	3.8e-07	2.01e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—PIK3CA—IgA glomerulonephritis	3.74e-07	1.97e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—PIK3CA—IgA glomerulonephritis	3.73e-07	1.97e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NRAS—IgA glomerulonephritis	3.72e-07	1.96e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ALB—IgA glomerulonephritis	3.72e-07	1.96e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—AGT—IgA glomerulonephritis	3.65e-07	1.93e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—PIK3CA—IgA glomerulonephritis	3.63e-07	1.92e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFB1—IgA glomerulonephritis	3.58e-07	1.89e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—MAPK1—IgA glomerulonephritis	3.51e-07	1.85e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CD44—IgA glomerulonephritis	3.5e-07	1.85e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NRAS—IgA glomerulonephritis	3.48e-07	1.84e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFB1—IgA glomerulonephritis	3.46e-07	1.82e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—PIK3CA—IgA glomerulonephritis	3.44e-07	1.82e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP9—IgA glomerulonephritis	3.44e-07	1.81e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PTEN—IgA glomerulonephritis	3.42e-07	1.8e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MAPK1—IgA glomerulonephritis	3.39e-07	1.79e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ABCA1—IgA glomerulonephritis	3.35e-07	1.77e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—PIK3CA—IgA glomerulonephritis	3.3e-07	1.74e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFB1—IgA glomerulonephritis	3.23e-07	1.71e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MAPK1—IgA glomerulonephritis	3.17e-07	1.67e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NRAS—IgA glomerulonephritis	3.05e-07	1.61e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—PIK3CA—IgA glomerulonephritis	3.05e-07	1.61e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP9—IgA glomerulonephritis	3.04e-07	1.6e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PTEN—IgA glomerulonephritis	3.02e-07	1.6e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PIK3CA—IgA glomerulonephritis	2.94e-07	1.55e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HMOX1—IgA glomerulonephritis	2.88e-07	1.52e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTEN—IgA glomerulonephritis	2.84e-07	1.5e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFB1—IgA glomerulonephritis	2.83e-07	1.49e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALB—IgA glomerulonephritis	2.8e-07	1.48e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MAPK1—IgA glomerulonephritis	2.78e-07	1.46e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PIK3CA—IgA glomerulonephritis	2.75e-07	1.45e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TYMS—IgA glomerulonephritis	2.71e-07	1.43e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NRAS—IgA glomerulonephritis	2.7e-07	1.42e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFB1—IgA glomerulonephritis	2.51e-07	1.32e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CD36—IgA glomerulonephritis	2.5e-07	1.32e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MAPK1—IgA glomerulonephritis	2.46e-07	1.3e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PIK3CA—IgA glomerulonephritis	2.41e-07	1.27e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—AGT—IgA glomerulonephritis	2.25e-07	1.19e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTEN—IgA glomerulonephritis	2.14e-07	1.13e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PIK3CA—IgA glomerulonephritis	2.13e-07	1.13e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PIK3CA—IgA glomerulonephritis	2e-07	1.06e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALB—IgA glomerulonephritis	1.73e-07	9.11e-07	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PIK3CA—IgA glomerulonephritis	1.51e-07	7.96e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTEN—IgA glomerulonephritis	1.32e-07	6.95e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PIK3CA—IgA glomerulonephritis	9.3e-08	4.91e-07	CbGpPWpGaD
